Cablivi: 4 Clinical Trials

Hide Studies Not Open or Pending

Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura

Condition(s):Acquired Thrombotic Thrombocytopenic PurpuraLast Updated:May 30, 2023Not yet recruiting

Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP

Condition(s):Acquired Thrombotic Thrombocytopenic PurpuraLast Updated:April 25, 2023Recruiting

Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)

Condition(s):Immune-mediated Thrombocytopenic PurpuraLast Updated:December 14, 2022Completed

Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

Condition(s):Thrombotic Thrombocytopenic PurpuraLast Updated:August 25, 2023Recruiting

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.